Lycia Therapeutics, Inc. (LYCA) revenue by segment
LYCANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$31.35+0.43 (+1.39%)
Close on Nov 18, 2026Market cap –P/E –Yield –
See a number that looks wrong?
Close on Nov 18, 2026Market cap –P/E –Yield –
See a number that looks wrong?